HLN is no longer actively traded. Data shown reflects verified historical relationships.
0Suppliers
11Customers
1Debt Items
20Related Chains

Haleon plc Suppliers

No suppliers on recordHaleon plc has not yet been matched to upstream suppliers in our database, or is still being processed.

Haleon plc Customers

TickerNameConfidenceEvidence
GSK GSK plc 72% tails below. Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA, UK +44 (0) 371 384 2227 www.shareview.co.uk Dividend services and bank mandate The Company only makes dividen…
GSK GSK plc 72% Reciprocal relationship from GSK graph: Reciprocal relationship from HLN graph: tails below. Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA, UK +44 (0) 371 384 2227 www.s…
BOARD-THE-GROUP BOARD-THE-GROUP 62% e arises from the foreign currency translation of the Group’s foreign operations into the Group’s presentation currency. ​ Retained earnings includes all current and prior years’ retained profits, re…
CARBON-NEUTRAL-COMPANY CARBON-NEUTRAL-COMPANY 62% tails below. Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA, UK +44 (0) 371 384 2227 www.shareview.co.uk Dividend services and bank mandate The Company only makes dividen…
EQUINITI-LIMITED EQUINITI-LIMITED 62% tails below. Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA, UK +44 (0) 371 384 2227 www.shareview.co.uk Dividend services and bank mandate The Company only makes dividen…
GSK-CONSUMER-HEALTHCARE-CAPITAL-US-LLC GSK-CONSUMER-HEALTHCARE-CAPITAL-US-LLC 62% tails below. Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA, UK +44 (0) 371 384 2227 www.shareview.co.uk Dividend services and bank mandate The Company only makes dividen…
GSK-GROUP GSK-GROUP 62% on the continuation of operations and/or sales, including a determination by the Group to discontinue all sales in such countries. — As part of the Russian Government’s indicated plans to seize the a…
OTHER-INFORMATION-GROUP OTHER-INFORMATION-GROUP 62% fect the Group through their impact on payroll and supply costs (including freight). Whilst the Group may increase product prices in order to mitigate the impact of inflation, competitive pressures m…
PFIZER-COMPLETION-THE-GROUP PFIZER-COMPLETION-THE-GROUP 62% on the continuation of operations and/or sales, including a determination by the Group to discontinue all sales in such countries. — As part of the Russian Government’s indicated plans to seize the a…
PFIZER-GROUP PFIZER-GROUP 62% on the continuation of operations and/or sales, including a determination by the Group to discontinue all sales in such countries. — As part of the Russian Government’s indicated plans to seize the a…
US-PUBLIC-COMPANY US-PUBLIC-COMPANY 62% es income and expense from all other operating activities which are not related to the ordinary course of business of the Group, such as gains/losses from disposals and transaction-related costs. ​ I…

Haleon plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
HLN-DEBT Debt stack $11.5B 90% Market cache reports total debt of $11.5B.

Haleon plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Haleon plc.

Haleon plc Ownership

HolderNameConfidenceEvidence
HLN-OWNER-ARISTOTLE-CAPITAL-MANAGEMENT-LLC Aristotle Capital Management, LLC 90% 13F overlay lists Aristotle Capital Management, LLC as top holder; 2 tracked holders.

Haleon plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CBIO Crescent Biopharma, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
BDRX Biodexa Pharmaceuticals Plc 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CVS CVS Health Corporation 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CLX The Clorox Company 100.00 1 ['receiving']
ANRO Alto Neuroscience, Inc. 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
EMN Eastman Chemical Company 100.00 2
DEO Diageo plc 100.00 1 ['receiving']
BNBX BNB Plus Corp. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
IHG InterContinental Hotels Group PLC 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2